Pharma Zen

PharmaZen, operating primarily under the brand Waitaki Biosciences, is a New Zealand-based biotechnology company specializing in the development and manufacture of high-value nutraceutical ingredients. The company utilizes proprietary extraction and freeze-drying technologies to process marine and land-based biological materials into bioactive compounds for the global health and wellness market. Its core product portfolio includes green-lipped mussel extracts, bovine bone hydroxyapatite, and marine collagen, which target joint health, bone density, and inflammatory conditions. PharmaZen serves as a key supplier to the international dietary supplement, functional food, and personal care industries. In late 2023, the company was acquired by Ballygowan Limited and transitioned from a public listing on the Unlisted Securities Exchange to private ownership.